tyrosine has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Qiao, S; Wang, H; Wang, T | 1 |
Fan, YF; Ge, GB; Hou, FB; Pan, QS; Qian, XK; Wang, P; Xiang, YW; Zhao, DF; Zhu, SX | 1 |
Bernardes, SS; Cecchini, AL; Cecchini, R; da Silva, CF; de Souza-Neto, FP; Derossi, DR; Guarnier, FA; Melo, GP; Ramalho, LN; Simão, AN | 1 |
1 review(s) available for tyrosine and Dysplastic Nevus Syndrome, Hereditary
Article | Year |
---|---|
Spectrophotometric Assays for Sensing Tyrosinase Activity and Their Applications.
Topics: Biosensing Techniques; Humans; Kinetics; Melanoma; Melanoma, Cutaneous Malignant; Monophenol Monooxygenase; Oxidation-Reduction; Skin Neoplasms; Spectrophotometry; Tyrosine | 2021 |
2 other study(ies) available for tyrosine and Dysplastic Nevus Syndrome, Hereditary
Article | Year |
---|---|
Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis.
Topics: Breast Neoplasms; Ceramides; Female; Humans; Lipid Metabolism; Melanoma, Cutaneous Malignant; Neoplasms, Second Primary; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases, Non-Receptor; Protein-Tyrosine Kinases; Tyrosine | 2023 |
Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients.
Topics: Adult; Aged; Female; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Oxidative Stress; Skin Neoplasms; Tumor Microenvironment; Tyrosine; Young Adult | 2015 |